# Session Analysis: Mechanobiology × Enhancer Epigenomics
## Session: 2026-03-25-targeted-002 | Generated: 2026-03-25
## Agent: session-analyst-v5.2

---

## Session Overview

- **Session ID**: 2026-03-25-targeted-002
- **Mode**: Targeted (user-specified)
- **Target**: Mechanobiology (ECM mechanics) × Epigenomics (enhancer regulation)
- **Session number**: 015 (based on discovery-log.json)
- **Disjointness**: PARTIALLY_EXPLORED — unusual for this pipeline (prior sessions: predominantly DISJOINT)
- **Cycle decision**: Standard (cycle 1 only, no cycle 2 triggered)
- **Total hypotheses**: 5 generated, 0 killed, 3 passed quality gate, 2 evolved
- **Kill rate**: 0% — lowest in pipeline history
- **Quality gate pass rate**: 60% (3/5) — highest PARTIALLY_EXPLORED result
- **Evolution productivity**: Both evolved hypotheses (H1e, H5e) are mechanistically coherent and testable

---

## 1. Strategy Performance

**Mode was targeted** — Scout did not select a strategy; user provided the target domain. Meta-learning for strategy performance is not applicable this session. However, two meta-observations are relevant:

### 1a. PARTIALLY_EXPLORED can be productive when the landmark paper is RECENT

This session contradicts the standing recommendation to never select PARTIALLY_EXPLORED when DISJOINT alternatives exist. The intersection was "newly opened" by Cosgrove et al. 2025 (Science), published ~3 months before this session. The landmark paper itself created the research gaps being explored. This is a distinct category:

**NEWLY_OPENED_PARTIALLY_EXPLORED** — where a recent landmark paper established the subfield and immediately adjacent mechanistic questions are unstudied. Distinct from traditional PARTIALLY_EXPLORED (where multiple papers bridge the fields). Session produced 3/5 quality gate pass rate, the best result for any PARTIALLY_EXPLORED session.

**New heuristic (S015)**: When a recently published (< 6 months) landmark paper defines a new subfield, the PARTIALLY_EXPLORED status does not reflect saturation — it reflects novelty. The landmark paper itself creates explorable gaps. When Literature Scout identifies such a "defining paper," treat the session as effectively DISJOINT for the *specific mechanistic gaps* the paper leaves open.

### 1b. Targeted mode produced higher epistemic density than comparable scout modes

5 hypotheses sharing a common hub protein (EP300) created complementary rather than redundant hypotheses. The single hub protein was identified by computational validation (STRING 0.988 EP300-BRD4, 0.908 EP300-CAMK2A, 0.710 EP300-MRTFA), and the hypotheses explore different *upstream* pathways to the same *downstream* hub. This "convergent hub" architecture is a productive hypothesis-generation pattern.

---

## 2. Kill Pattern Analysis

**Kill rate: 0%** — no hypotheses killed by critique. This is unusual and informative.

### Why zero kills?

All 5 hypotheses survived with CONDITIONAL verdicts. The common mechanism: each hypothesis had a **critical issue** that was a *scope/prerequisite problem* rather than a *fatal mechanistic flaw*:

- **H1**: False premise (bivalency) — rescued by scope narrowing to IPF/MSC cells where bivalency is plausible
- **H2**: Wrong mechanistic route (CaMKII→EP300 direct) — rescued by correcting to established CaMKII→HDAC4/5→EP300 indirect route
- **H3**: Nuclear import saturation alternative — rescued by adding IDR-deleted YAP discriminant control
- **H4**: False enhancer-preference claim — rescued by removing unsupported claim, retaining core CaRG-box occupation test
- **H5**: Wrong pharmacological control (verteporfin) — rescued by replacing with IDR-deleted YAP; 5 alternatives acknowledged

**Pattern**: When the landmark paper (Cosgrove 2025) establishes the field, the immediately adjacent hypotheses are harder to kill because the field's empirical gaps are documented, reducing the risk of false premises. The hypotheses are essentially "step 2" of Cosgrove's "step 1" — mechanistically plausible extensions of established work.

**Meta-learning**: Zero kills may indicate a hypothesis generation context where the Generator's parametric knowledge matches the literature well. EP300 hub centrality gave the Generator a verifiable protein scaffold that proved robust across 9 adversarial attack vectors.

---

## 3. Bridge Type Analysis

### New bridge type identified: **Multi-pathway convergence on single HAT hub**

This session's bridge architecture is novel in pipeline history:

| Prior bridge types | Session 015 bridge type |
|---|---|
| A→B single mechanism | Paths A1, A2, A3 → Hub B (EP300) |
| Tool transfer (A into C) | Multiple upstream signals converging on single downstream effector |
| Mathematical law constraint | Each path has different kinetics, cell-type specificity, molecular specificity |

**Characteristics**:
- Hub protein (EP300) is the intersection of mechanosensory signals (Piezo1, YAP, MRTF)
- Each hypothesis explores a DIFFERENT upstream pathway to the SAME downstream effector
- This creates naturally non-redundant hypotheses (complementary mechanistic classes)
- Hub protein identified by computational validation (STRING co-expression + experimental scores)
- Allows temporal layering: fast upstream (Piezo1→CaMKII, <15 min) + slow upstream (YAP nuclear, 30-60 min)

**Mechanism for high hypothesis density**: The hub protein architecture means that as long as the hub (EP300) is well-supported (STRING 0.988 with BRD4), hypotheses exploring different hub inputs are automatically non-redundant. This is a productive generator pattern for future sessions.

**New heuristic (S015)**: "Hub protein discovery first, upstream diversity second" — use computational validation to identify a single protein that bridges both fields (high STRING scores with both Field A proteins and Field C proteins). Then generate hypotheses exploring *different upstream pathways* to the hub. This prevents hypothesis redundancy while guaranteeing cross-field grounding.

---

## 4. Attack Vector Effectiveness (from critique)

5 hypotheses × 9 attack vectors = 45 attack vector applications.

**Most productive attack vectors** (produced the most useful hypothesis improvements):

| Attack Vector | Applied to | Outcome |
|---|---|---|
| FALSE_PREMISE | H1 (bivalency), H4 (enhancer preference), H5 (86.2% looping) | CRITICAL severity; produced meaningful scope corrections |
| MECHANISTIC_CHAIN | H2 (CaMKII→EP300), H4 (EP300 via SRF vs independent), H1 (KDM6B at enhancers) | CRITICAL/MODERATE; mechanistic route corrections |
| ALTERNATIVE_EXPLANATION | H3 (nuclear import saturation), H5 (5 competing mechanisms) | MAJOR; produced key discriminant controls |
| CONTEXT_GENERALIZABILITY | H1 (MSC → fibroblast), H3 (cancer → fibroblast), H5 (cancer → fibroblast) | MODERATE; produced cell-type specificity improvements |

**Least productive attack vectors** (no critiques generated):
- QUANTITATIVE_FEASIBILITY: Only produced moderate concern for H3 (256x condensate size upper bound) — did not change hypothesis
- PRIOR_SATURATION: All 5 hypotheses passed novelty verification (0 kills from prior saturation)

**Attack vector effectiveness ranking for this session**:
1. FALSE_PREMISE → CRITICAL improvements (2/5 hypotheses)
2. MECHANISTIC_CHAIN → CRITICAL improvements (2/5 hypotheses)
3. ALTERNATIVE_EXPLANATION → Added discriminant controls (2/5 hypotheses)
4. CONTEXT_GENERALIZABILITY → Cell-type scoping (3/5 hypotheses)

---

## 5. Quality Gate Performance

| Hypothesis | Rank | Score | QG Result | Confidence change | Key new evidence |
|---|---|---|---|---|---|
| H3 | 1 | 7.85 | PASS 10/10 | 0.58 → 0.63 | iScience 2024 PMID 38784009 (endogenous YAP-BRD4 condensates + actin tension) |
| H4 | 2 | 7.55 | PASS 10/10 | 0.60 → 0.62 | MYH9 CaRG mechanoenhancer H3K27ac data (Cosgrove 2025 extended) |
| H2 | 3 | 7.50 | PASS 10/10 | 0.55 → 0.60 | CaMKII 3-min activation confirmed; PMID 23804765 nuclear CaMKII→H3S10ph |

**Quality gate discovery**: iScience 2024 (PMID 38784009) was found DURING quality gate verification — not in the initial literature scout. This paper directly establishes endogenous YAP condensates with TEAD1+BRD4 in response to actin cytoskeletal tension. This is exactly the cellular context relevant to ECM stiffness mechanosensing. Its discovery during QG (rather than during literature scouting) significantly improved H3's groundedness.

**Lesson**: Quality Gate web verification can find papers missed by Literature Scout when search terms are hypothesis-specific rather than field-level. The literature scout searched for "YAP BRD4 condensates" broadly; the QG searched specifically for "endogenous YAP condensates actin tension fibroblast" — the more specific query returned the 2024 paper.

---

## 6. Evolution Productivity

Both evolution operations produced coherent improvements:

| Evolved | Operation | Key advance | Net quality change |
|---|---|---|---|
| H1 → H1e | Cell-type mutation + specification | Converts "unverified premise in wrong cell type" to "verifiable premise in correct cell type"; adds IPF clinical angle | Confidence: 0.62 → 0.56 (appropriate — lower confidence as IPF-specific, but hypothesis is now testable) |
| H5 → H5e | Crossover H5 × H3 + quantitative specification | Adds condensate volume threshold (from H3 model) to looping-independent mechanism (H5); directly explains 86.2% anomaly | Confidence: 0.52 → 0.53 (marginal increase; main gain is discriminability, not groundedness) |

**Evolution observation**: H5e's crossover with H3 created a hypothesis that explains the session's key anomaly (86.2% looping-independent connections). The key insight was that H3's supralinear encoding predicts a condensate size threshold, and H5's looping-independent premise needs a spatial proximity mechanism. The crossover unites them: condensate size threshold = spatial capture radius threshold. This is a mechanistically elegant evolution.

---

## 7. Session-Level Creativity Metrics

| Metric | Value | Notes |
|---|---|---|
| Mean disciplinary distance | 2.6 (of 3 max) | H3, H2, H5e span 3 disciplines; H4, H1e span 2 |
| Abstraction level | Mechanism-specific (concrete) | All hypotheses specify proteins, assays, predictions |
| Novelty type | Gap-filling (adjacent to landmark paper) | Step 2 of Cosgrove 2025's step 1 |
| Hub protein architecture | YES — EP300 central | Novel pipeline pattern; 3 upstream paths to 1 downstream hub |
| Cross-session anomaly leveraged | YES — 86.2% looping-independent | Built into multiple hypotheses; directly addressed by H5e |

---

## 8. Recommendations for Future Sessions

Based on this session's patterns:

1. **NEWLY_OPENED_PARTIALLY_EXPLORED is viable** (heuristic above). When a recent landmark paper defines a new subfield, treat the session as targeting fresh mechanistic gaps.

2. **Hub protein identification before hypothesis generation** increases hypothesis density. Computational validation showing one protein (EP300) with high STRING scores to BOTH field A proteins (YAP, CAMK2A, MRTFA) and field C markers (BRD4, TEAD1) should be recognized as a "convergence hub" signal.

3. **Literature scout anomaly detection is hypothesis-generative**. The 86.2% looping-independent anomaly from Cosgrove 2025 directly generated H5 and H5e. Actively searching for numerical anomalies in landmark papers (unexpected percentages, unexpected trends) should be a Literature Scout priority.

4. **QG verification should include hypothesis-specific search terms**, not just field-level terms. This session found a critical paper (iScience 2024) during QG that was missed during literature scouting. Narrowing to hypothesis-specific protein + context + year combinations can surface more relevant papers.

5. **Evolution fodder with "cell-type mismatch" problems** are well-suited to CELL_TYPE_MUTATION operations. When the critique identifies that the evidence base is from a different cell type, the most productive evolution is to identify the cell type WHERE the premise does hold and reframe accordingly.
